EUVIMEDEUVIMED entdecken
Open Access

PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth

Si Chen iD, Jiawei Chen, Wenting Du, Deanne M Mickelsen iD, Hangchuan Shi iD, Han Yu, Sparsh Kumar iD, Chen Yan iD

Circulation Research · 07.07.2023 · 133 (2) · 138-157

DOI: 10.1161/circresaha.122.322264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 07.07.2023. Verfasst von Si Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine (S.C., J.C., W.D., D.M.M., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY. Hauptthemen laut MEDLINE: Cardiotoxicity, Ovarian Neoplasms. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cyclic nucleotides play critical roles in cardiovascular biology and disease. PDE10A (phosphodiesterase 10A) is able to hydrolyze both cAMP and cGMP. PDE10A expression is induced in various human tumor cell lines, and PDE10A inhibition suppresses tumor cell growth. Chemotherapy drug such as doxorubicin (DOX) is widely used in chemotherapy. However, cardiotoxicity of DOX remains to be a serious clinical complication. In the current study, we aim to determine the role of PDE10A and the effect of PDE10A inhibition on cancer growth and cardiotoxicity induced by DOX.

Methods

We used global PDE10A knockout (KO) mice and PDE10A inhibitor TP-10 to block PDE10A function. DOX-induced cardiotoxicity was evaluated in C57Bl/6J mice and nude mice with implanted ovarian cancer xenografts. Isolated adult mouse cardiomyocytes and a human ovarian cancer cell line were used for in vitro functional and mechanistic studies.

Results

We found that PDE10A deficiency or inhibition alleviated DOX-induced myocardial atrophy, apoptosis, and dysfunction in C57Bl/6J mice. RNA sequencing study revealed a number of PDE10A-regulated signaling pathways involved in DOX-induced cardiotoxicity. PDE10A inhibition increased the death, decreased the proliferation, and potentiated the effect of DOX on various human cancer cells. Importantly, in nude mice with implanted ovarian cancer xenografts, PDE10A inhibition attenuated tumor growth while protecting DOX-induced cardiotoxicity. In isolated cardiomyocytes, PDE10A contributed to DOX-induced cardiomyocyte death via increasing Top2β (topoisomerase 2β) expression, mitochondrial dysfunction, and DNA damage by antagonizing cGMP/PKG (protein kinase G) signaling. PDE10A contributed to cardiomyocyte atrophy via potentiating FoxO3 (forkhead box O3) signaling via both cAMP/PKA (protein kinase A)- and cGMP/PKG-dependent signaling.

Conclusions

Taken together, our study elucidates a novel role for PDE10A in cardiotoxicity induced by DOX and cancer growth. Given that PDE10A has been already proven to be a safe drug target, PDE10A inhibition may represent a novel therapeutic strategy in cancer therapy, with effects preventing DOX-induced cardiotoxicity and simultaneously antagonizing cancer growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityOvarian NeoplasmsAnimalsFemaleHumansMiceApoptosisAtrophyDoxorubicinMice, Inbred C57BLMice, KnockoutMice, NudeMyocytes, CardiacOxidative StressPhosphoric Diester Hydrolases

Stichwörter der Autor:innen

cardiotoxicitydoxorubicinnucleotides, cyclicovarian neoplasmsphosphoric diester hydrolases

Substanzen

DoxorubicinPDE10A protein, humanPhosphoric Diester Hydrolases

Autor:innen und Institutionen

  • Departments of Medicine (S.C., J.C., W.D., D.M.M., C.Y.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Now with Department of Cardiology, Ruijin Hospital (J.C.), Shanghai Jiao-Tong University School of Medicine, China.
  • Institute of Cardiovascular Diseases (J.C.), Shanghai Jiao-Tong University School of Medicine, China.
  • Department of Geriatrics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China (W.D.).
  • Clinical and Translational Research (H.S.), University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY (H.Y.).

ORCID-Profile: Si Chen, Deanne M Mickelsen, Hangchuan Shi, Sparsh Kumar, Chen Yan

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Chen, S., Chen, J., Du, W., Mickelsen, D. M., Shi, H., Yu, H., Kumar, S., & Yan, C. (2023). PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth. Circulation Research, 133(2), 138-157. https://doi.org/10.1161/circresaha.122.322264

Vancouver

Chen S, Chen J, Du W, Mickelsen DM, Shi H, Yu H, et al. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth. Circulation Research. 2023;133(2):138-157. doi:10.1161/circresaha.122.322264

BibTeX
@article{Chen2023,
  author = {Chen, Si and Chen, Jiawei and Du, Wenting and Mickelsen, Deanne M and Shi, Hangchuan and Yu, Han and Kumar, Sparsh and Yan, Chen},
  title = {PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth},
  journal = {Circulation Research},
  year = {2023},
  volume = {133},
  number = {2},
  pages = {138--157},
  doi = {10.1161/circresaha.122.322264}
}
Kostenlos starten →